Scholastic Posts Downbeat Q1 Results, Joins Legacy Education, Zscaler And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Scholastic reported a Q1 loss of $3.63 per share versus the $3.40 loss consensus and revenue of $216.8 million versus $224.7 million expected, sending shares down 9.9% to $31.38 in pre-market trading. Other notable decliners included Legacy Education, down 13.1%, while Zscaler fell 3.6% following its appointment of Ross Tackett as chief revenue officer. Despite the company-specific weakness, Dow futures were up roughly 100 points.

Analysis

SCHL’s miss matters less for the absolute quarter than for what it implies about the elasticity of school/library and consumer-book budgets entering the key second-half selling cycle. A revenue shortfall alongside a wider loss raises the probability that fixed-cost absorption—not merely timing—remains impaired; that would pressure FY operating-margin expectations and justify a lower multiple until management demonstrates better order conversion. The cleaner read-through is cautiously negative for education-content peers exposed to institutional budgets, but limited for broader publishers whose adult trade exposure and digital mix differ.

The most actionable signal is in ZS: a CRO transition creates a near-term execution overhang precisely where investors require evidence that large-platform cyber vendors can sustain billings growth while defending margins. The move is not thesis-changing without a guidance revision, but it raises the bar for the next earnings call; PANW and CRWD could gain relative-flow support if ZS sales productivity or federal/large-enterprise conversion weakens. Conversely, if the new CRO is an internal succession with no change to quota attainment or pipeline coverage, the pre-market weakness is likely a liquidity-driven entry opportunity rather than fundamental deterioration.

SRZN’s post-spike pullback is typical binary-biotech financing risk, not a valuation signal. An IND submission does not establish clinical probability, while the large prior-day move increases the odds of an ATM, follow-on, or warrant-related supply before meaningful human data; avoid chasing unless cash runway and trial-start guidance are independently confirmed. CNXC is a higher-quality event watch: its forthcoming report can reset sentiment around AI-driven contact-center deflation versus productivity-led margin expansion, with implications for peers TTEC and TASK over the next one to three months.

Key Decisions for Investors

• SCHL: remain underweight; consider a 1-3 month short only on a failed rebound below the post-report gap, with a tight stop on evidence that deferred school orders—not demand loss—caused the miss. Cover if management reaffirms full-year revenue and margin targets with confirmed backlog conversion.
• ZS: use a further 5-8% non-fundamental selloff to initiate a small tactical long versus short PANW or CRWD only after confirming no reduction in sales guidance or material CRO departure language. Target relative mean reversion into the next earnings event; exit on disclosed pipeline deterioration or lowered billings outlook.
• CNXC: no position before earnings; establish an alert for bookings, client retention, and adjusted operating-margin guidance. A credible margin expansion despite flat-to-down revenue would support a tactical long against TTEC; weak guidance would favor short CNXC rather than extrapolating the pre-event drift.
• SRZN: avoid directional exposure through expected financing window. If SEC filings show at least 18 months of cash runway and no new equity issuance after the IND acceptance/trial-start update, reassess for a small catalyst long; otherwise treat rallies as potential dilution liquidity.